These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 20139819

  • 1. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
    Steffen IG, Mehl S, Heuck F, Elgeti F, Furth C, Amthauer H, Ruf J.
    Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
    [Abstract] [Full Text] [Related]

  • 2. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT.
    Ruf J, Steffen I, Mehl S, Rosner C, Denecke T, Pape UF, Plotkin M, Amthauer H.
    Nucl Med Commun; 2007 Oct; 28(10):782-8. PubMed ID: 17728608
    [Abstract] [Full Text] [Related]

  • 3. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y, Wong KH, Sun M, Franc BL, Hawkins RA, Hasegawa BH.
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [Abstract] [Full Text] [Related]

  • 4. Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
    Wong KK, Cahill JM, Frey KA, Avram AM.
    Acad Radiol; 2010 Mar; 17(3):291-7. PubMed ID: 19962915
    [Abstract] [Full Text] [Related]

  • 5. Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET.
    Fricke E, Fricke H, Weise R, Kammeier A, Hagedorn R, Lotz N, Lindner O, Tschoepe D, Burchert W.
    J Nucl Med; 2005 May; 46(5):736-44. PubMed ID: 15872344
    [Abstract] [Full Text] [Related]

  • 6. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H, Zhu R.
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [Abstract] [Full Text] [Related]

  • 7. Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.
    Ruf J, Heuck F, Schiefer J, Denecke T, Elgeti F, Pascher A, Pavel M, Stelter L, Kropf S, Wiedenmann B, Amthauer H.
    Neuroendocrinology; 2010 Dec; 91(1):101-9. PubMed ID: 19996582
    [Abstract] [Full Text] [Related]

  • 8. SPECT/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings: a retrospective analysis of inter-rater agreement.
    Apostolova I, Riethdorf S, Buchert R, Derlin T, Brenner W, Mester J, Klutmann S.
    Ann Nucl Med; 2010 Jul; 24(6):477-83. PubMed ID: 20449694
    [Abstract] [Full Text] [Related]

  • 9. Directions and magnitudes of misregistration of CT attenuation-corrected myocardial perfusion studies: incidence, impact on image quality, and guidance for reregistration.
    Kennedy JA, Israel O, Frenkel A.
    J Nucl Med; 2009 Sep; 50(9):1471-8. PubMed ID: 19690038
    [Abstract] [Full Text] [Related]

  • 10. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D, Gabriel M, Henninger B, Kendler D, Uprimny C, Dobrozemsky G, Decristoforo C, Bale RJ, Jaschke W, Virgolini IJ.
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [Abstract] [Full Text] [Related]

  • 11. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
    Ingui CJ, Shah NP, Oates ME.
    Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
    [Abstract] [Full Text] [Related]

  • 12. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
    Nagarajah J, Dannat T, Hartung V, Bockisch A, Rosenbaum-Krumme S.
    Nuklearmedizin; 2012 Feb; 51(3):84-7. PubMed ID: 22366817
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
    Gabriel M, Hausler F, Bale R, Moncayo R, Decristoforo C, Kovacs P, Virgolini I.
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
    Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM.
    AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.